Learn More
Medchemexpress LLC Afimetoran (BMS-986256) | 2171019-55-7 | 99.4% | 444.57 | 50 MG

Supplier: Medchemexpress LLC HY13956750MG
Afimetoran (BMS-986256) is an orally active, selective, and highly bioavailable antagonist of Toll-like Receptor 7 and 8 (TLR7/8). It operates by inhibiting the activation of the NF-κB pathway, which is crucial in immune responses. Furthermore, Afimetoran can reverse TLR7-mediated resistance to steroid-induced apoptosis in plasma cell-like dendritic cells (pDCs). This compound is valuable for research into inflammation and autoimmune diseases, such as systemic lupus erythematosus.
- Orally active
- Selective TLR7/8 antagonist
- Highly bioavailable
- Inhibits NF-κB pathway
- Reverses steroid resistance
- Research applications
- Demonstrated in vivo efficacy
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.